Sponsors: []Modifications: :(a);(b); or(c)  otherwise legally ingested.Alcoholic Beverage Control Act,(v)  "Indian" means a member of an Indian tribe.(w)  "Indian religion" means any religion:(i)  the origin and interpretation of which is from within a traditional Indian culture orcommunity; and(ii)  which is practiced by Indians.(x)  "Indian tribe" means any tribe, band, nation, pueblo, or other organized group orcommunity of Indians, including any Alaska Native village, which is recognized as eligible forthe special programs and services provided by the United States to Indians because of theirstatus as Indians.(y)(z)(aa)(bb)(cc)(cc)(dd)(ee)(ff)(gg)(hh)(ii)(jj)(kk)(ll)(mm)(nn)(oo)(pp);this chapter(10) (a)  Civil or criminal liability may not be imposed under this section on any Indian,as defined in Subsection 

58-37-2

(1)(v), who uses, possesses, or transports peyote for bona fidetraditional ceremonial purposes in connection with the practice of a traditional Indian religionas defined in Subsection 

58-37-2

(1)(w).(b)  In a prosecution alleging violation of this section regarding peyote as defined inSubsection 

58-37-4

(2)(a)(iii)(V), it is an affirmative defense that the peyote was used,possessed, or transported by an Indian for bona fide traditional ceremonial purposes inconnection with the practice of a traditional Indian religion.(c) (i)  The defendant shall provide written notice of intent to claim an affirmativedefense under this Subsection (10) as soon as practicable, but not later than ten days prior totrial.(ii)  The notice shall include the specific claims of the affirmative defense.(iii)  The court may waive the notice requirement in the interest of justice for goodcause shown, if the prosecutor is not unfairly prejudiced by the lack of timely notice.(d)  The defendant shall establish the affirmative defense under this Subsection (10) bya preponderance of the evidence.  If the defense is established, it is a complete defense to thecharges.(11)Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WordPerfect HB0060.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 60





            
1

    
 CONTROLLED SUBSTANCE AMENDMENTS


            
2

    
2006 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    
 Chief Sponsor:  Curtis Oda

            
5

    

Senate Sponsor: 


  Gregory S. Bell



            
6

    

            
7

    
 LONG TITLE
            
8

    
 General Description:
            
9

    
    This bill amends the Controlled Substances Act to clarify the scope of the exception
            
10

    
established for the ceremonial use of peyote by Indians in traditional Indian religion and
            
11

    
to provide an affirmative defense.
            
12

    
 Highlighted Provisions:
            
13

    
    This bill:
            
14

    
    .    provides definitions in the Controlled Substances Act of "Indian," "Indian religion,"
            
15

    
and "Indian tribe" in order to provide for the determination of individuals who are
            
16

    
members of Indian tribes regarding the peyote use exemption;
            
17

    
    .    provides an affirmative defense against a charge for possession of peyote if used by
            
18

    
an Indian in an Indian religious ceremony, as these terms are defined in this bill; and
            
19

    
    .    provides related qualifying language regarding driving with any measurable
            
20

    
controlled substance in the body.
            
21

    
 Monies Appropriated in this Bill:
            
22

    
    None
            
23

    
 Other Special Clauses:
            
24

    
    None
            
25

    
 Utah Code Sections Affected:
            
26

    
AMENDS:
            
27

    
     41-6a-517, as renumbered and amended by Chapter 2 and last amended by Chapter

            
28


    
283, Laws of Utah 2005
            
29

    
     58-37-2, as last amended by Chapter 283, Laws of Utah 2005
            
30

    
     58-37-4, as last amended by Chapter 33, Laws of Utah 2003
            
31

    
     58-37-8, as last amended by Chapter 30, Laws of Utah 2005
            
32

    

            
33

    
Be it enacted by the Legislature of the state of Utah:
            
34

    
    Section 1.  
Section  
41-6a-517

 is amended to read:
            
35

    
     41-6a-517.  Definitions -- Driving with any measurable controlled substance in the
            
36

    
 body -- Penalties -- Arrest without warrant.
            
37

    
    (1)  As used in this section:
            
38

    
    (a)  "Controlled substance" means any substance scheduled under Section 

58-37-4

.
            
39

    
    (b)  "Practitioner" has the same meaning as provided in Section 

58-37-2

.
            
40

    
    (c)  "Prescribe" has the same meaning as provided in Section 

58-37-2

.
            
41

    
    (d)  "Prescription" has the same meaning as provided in Section 

58-37-2

.
            
42

    
    (2)  In cases not amounting to a violation of Section 

41-6a-502

, a person may not
            
43

    
operate or be in actual physical control of a motor vehicle within this state if the person has any
            
44

    
measurable controlled substance or metabolite of a controlled substance in the person's body.
            
45

    
    (3)  It is an affirmative defense to prosecution under this section that the controlled
            
46

    
substance was:
            
47

    
    (a)  involuntarily ingested by the accused [or];
            
48

    
    (b)  prescribed by a practitioner for use by the accused[.]; or
            
49

    
    (c)  otherwise legally ingested.
            
50

    
    (4) (a)  A person convicted of a violation of Subsection (2) is guilty of a class B
            
51

    
misdemeanor.
            
52

    
    (b)  A person who violates this section is subject to conviction and sentencing under
            
53

    
both this section and any applicable offense under Section 

58-37-8

.
            
54

    
    (5)  A peace officer may, without a warrant, arrest a person for a violation of this
            
55

    
section when the officer has probable cause to believe the violation has occurred, although not
            
56

    
in the officer's presence, and if the officer has probable cause to believe that the violation was
            
57

    
committed by the person.
            
58

    
    (6)  The Driver License Division shall:

            
59


    
    (a)  suspend, for 90 days, the driver license of a person convicted under Subsection (2);
            
60

    
    (b)  revoke, for one year, the driver license of a person convicted of a second or
            
61

    
subsequent offense under Subsection (2) or if the person has a prior conviction as defined
            
62

    
under Subsection 

41-6a-501

(2), if the violation is committed within a period of ten years after
            
63

    
the date of the prior violation; and
            
64

    
    (c)  subtract from any suspension or revocation period the number of days for which a
            
65

    
license was previously suspended under Section 

53-3-223

 or 

53-3-231

, if the previous
            
66

    
suspension was based on the same occurrence upon which the record of conviction is based.
            
67

    
    (7) (a)  The court shall notify the Driver License Division if a person fails to:
            
68

    
    (i)  complete all court ordered screening and assessment, educational series, and
            
69

    
substance abuse treatment; or
            
70

    
    (ii)  pay all fines and fees, including fees for restitution and treatment costs.
            
71

    
    (b)  Upon receiving the notification, the division shall suspend the person's driving
            
72

    
privilege in accordance with Subsections 

53-3-221

(2) and (3).
            
73

    
    (8)  The court shall order supervised probation in accordance with Section 

41-6a-507


            
74

    
for a person convicted under Subsection (2).
            
75

    
    Section 2.  
Section  
58-37-2

 is amended to read:
            
76

    
     58-37-2.  Definitions.
            
77

    
    (1)  As used in this chapter:
            
78

    
    (a)  "Administer" means the direct application of a controlled substance, whether by
            
79

    
injection, inhalation, ingestion, or any other means, to the body of a patient or research subject
            
80

    
by:
            
81

    
    (i)  a practitioner or, in his presence, by his authorized agent; or
            
82

    
    (ii)  the patient or research subject at the direction and in the presence of the
            
83

    
practitioner.
            
84

    
    (b)  "Agent" means an authorized person who acts on behalf of or at the direction of a
            
85

    
manufacturer, distributor, or practitioner but does not include a motor carrier, public
            
86

    
warehouseman, or employee of any of them.
            
87

    
    (c)  "Consumption" means ingesting or having any measurable amount of a controlled
            
88

    
substance in a person's body, but this Subsection (1)(c) does not include the metabolite of a
            
89

    
controlled substance.

            
90


    
    (d)  "Continuing criminal enterprise" means any individual, sole proprietorship,
            
91

    
partnership, corporation, business trust, association, or other legal entity, and any union or
            
92

    
groups of individuals associated in fact although not a legal entity, and includes illicit as well
            
93

    
as licit entities created or maintained for the purpose of engaging in conduct which constitutes
            
94

    
the commission of episodes of activity made unlawful by Title 58, Chapters 37, 37a, 37b, 37c,
            
95

    
or 37d, which episodes are not isolated, but have the same or similar purposes, results,
            
96

    
participants, victims, methods of commission, or otherwise are interrelated by distinguishing
            
97

    
characteristics.  Taken together, the episodes shall demonstrate continuing unlawful conduct
            
98

    
and be related either to each other or to the enterprise.
            
99

    
    (e)  "Control" means to add, remove, or change the placement of a drug, substance, or
            
100

    
immediate precursor under Section 

58-37-3

.
            
101

    
    (f) (i)  "Controlled substance" means a drug or substance included in Schedules I, II, III,
            
102

    
IV, or V of Section 

58-37-4

, and also includes a drug or substance included in Schedules I, II,
            
103

    
III, IV, or V of the federal Controlled Substances Act, Title II, P.L. 91-513, or any controlled
            
104

    
substance analog.
            
105

    
    (ii)  "Controlled substance" does not include:
            
106

    
    (A)  distilled spirits, wine, or malt beverages, as those terms are defined or used in Title
            
107

    
32A, Alcoholic Beverage Control Act, regarding tobacco or food;
            
108

    
    (B)  any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
            
109

    
prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
            
110

    
norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
            
111

    
transferred, or furnished as an over-the-counter medication without prescription; or
            
112

    
    (C)  dietary supplements, vitamins, minerals, herbs, or other similar substances
            
113

    
including concentrates or extracts, which are not otherwise regulated by law, which may
            
114

    
contain naturally occurring amounts of chemical or substances listed in this chapter, or in rules
            
115

    
adopted pursuant to Title 63, Chapter 46a, Utah Administrative Rulemaking Act.
            
116

    
    (g) (i)  "Controlled substance analog" means a substance the chemical structure of
            
117

    
which is substantially similar to the chemical structure of a controlled substance listed in
            
118

    
Schedules I and II of Section 

58-37-4

, or in Schedules I and II of the federal Controlled
            
119

    
Substances Act, Title II, P.L. 91-513:
            
120

    
    (A)  which has a stimulant, depressant, or hallucinogenic effect on the central nervous

            
121


    
system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central
            
122

    
nervous system of controlled substances in the schedules set forth in Subsection (1)(f); or
            
123

    
    (B)  which, with respect to a particular individual, is represented or intended to have a
            
124

    
stimulant, depressant, or hallucinogenic effect on the central nervous system substantially
            
125

    
similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of
            
126

    
controlled substances in the schedules set forth in this Subsection (1).
            
127

    
    (ii)  "Controlled substance analog" does not include:
            
128

    
    (A)  a controlled substance currently scheduled in Schedules I through V of Section
            
129

    

58-37-4

;
            
130

    
    (B)  a substance for which there is an approved new drug application;
            
131

    
    (C)  a substance with respect to which an exemption is in effect for investigational use
            
132

    
by a particular person under Section 505 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 366,
            
133

    
to the extent the conduct with respect to the substance is permitted by the exemption;
            
134

    
    (D)  any substance to the extent not intended for human consumption before an
            
135

    
exemption takes effect with respect to the substance;
            
136

    
    (E)  any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
            
137

    
prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
            
138

    
norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
            
139

    
transferred, or furnished as an over-the-counter medication without prescription; or
            
140

    
    (F)  dietary supplements, vitamins, minerals, herbs, or other similar substances
            
141

    
including concentrates or extracts, which are not otherwise regulated by law, which may
            
142

    
contain naturally occurring amounts of chemical or substances listed in this chapter, or in rules
            
143

    
adopted pursuant to Title 63, Chapter 46a, Utah Administrative Rulemaking Act.
            
144

    
    (h)  "Conviction" means a determination of guilt by verdict, whether jury or bench, or
            
145

    
plea, whether guilty or no contest, for any offense proscribed by Title 58, Chapters 37, 37a,
            
146

    
37b, 37c, or 37d, or for any offense under the laws of the United States and any other state
            
147

    
which, if committed in this state, would be an offense under Title 58, Chapters 37, 37a, 37b,
            
148

    
37c, or 37d.
            
149

    
    (i)  "Counterfeit substance" means:
            
150

    
    (i)  any substance or container or labeling of any substance that without authorization
            
151

    
bears the trademark, trade name, or other identifying mark, imprint, number, device, or any

            
152


    
likeness of them, of a manufacturer, distributor, or dispenser other than the person or persons
            
153

    
who in fact manufactured, distributed, or dispensed the substance which falsely purports to be a
            
154

    
controlled substance distributed by, any other manufacturer, distributor, or dispenser; or
            
155

    
    (ii)  any substance that is represented to be a controlled substance.
            
156

    
    (j)  "Deliver" or "delivery" means the actual, constructive, or attempted transfer of a
            
157

    
controlled substance or a listed chemical, whether or not an agency relationship exists.
            
158

    
    (k)  "Department" means the Department of Commerce.
            
159

    
    (l)  "Depressant or stimulant substance" means:
            
160

    
    (i)  a drug which contains any quantity of barbituric acid or any of the salts of barbituric
            
161

    
acid;
            
162

    
    (ii)  a drug which contains any quantity of:
            
163

    
    (A)  amphetamine or any of its optical isomers;
            
164

    
    (B)  any salt of amphetamine or any salt of an optical isomer of amphetamine; or
            
165

    
    (C)  any substance which the Secretary of Health and Human Services or the Attorney
            
166

    
General of the United States after investigation has found and by regulation designated
            
167

    
habit-forming because of its stimulant effect on the central nervous system;
            
168

    
    (iii)  lysergic acid diethylamide; or
            
169

    
    (iv)  any drug which contains any quantity of a substance which the Secretary of Health
            
170

    
and Human Services or the Attorney General of the United States after investigation has found
            
171

    
to have, and by regulation designated as having, a potential for abuse because of its depressant
            
172

    
or stimulant effect on the central nervous system or its hallucinogenic effect.
            
173

    
    (m)  "Dispense" means the delivery of a controlled substance by a pharmacist to an
            
174

    
ultimate user pursuant to the lawful order or prescription of a practitioner, and includes
            
175

    
distributing to, leaving with, giving away, or disposing of that substance as well as the
            
176

    
packaging, labeling, or compounding necessary to prepare the substance for delivery.
            
177

    
    (n)  "Dispenser" means a pharmacist who dispenses a controlled substance.
            
178

    
    (o)  "Distribute" means to deliver other than by administering or dispensing a controlled
            
179

    
substance or a listed chemical.
            
180

    
    (p)  "Distributor" means a person who distributes controlled substances.
            
181

    
    (q)  "Division" means the Division of Occupational and Professional Licensing created
            
182

    
in Section 

58-1-103

.

            
183


    
    (r)  "Drug" means:
            
184

    
    (i)  articles recognized in the official United States Pharmacopoeia, Official
            
185

    
Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any
            
186

    
supplement to any of them;
            
187

    
    (ii)  articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention
            
188

    
of disease in man or other animals;
            
189

    
    (iii)  articles, other than food, intended to affect the structure or function of man or
            
190

    
other animals; and
            
191

    
    (iv)  articles intended for use as a component of any articles specified in Subsection
            
192

    
(1)(r)(i), (ii), or (iii); but does not include devices or their components, parts, or accessories.
            
193

    
    (s)  "Drug dependent person" means any individual who unlawfully and habitually uses
            
194

    
any controlled substance to endanger the public morals, health, safety, or welfare, or who is so
            
195

    
dependent upon the use of controlled substances as to have lost the power of self-control with
            
196

    
reference to his dependency.
            
197

    
    (t)  "Food" means:
            
198

    
    (i)  any nutrient or substance of plant, mineral, or animal origin other than a drug as
            
199

    
specified in this chapter, and normally ingested by human beings; and
            
200

    
    (ii)  foods for special dietary uses as exist by reason of a physical, physiological,
            
201

    
pathological, or other condition including but not limited to the conditions of disease,
            
202

    
convalescence, pregnancy, lactation, allergy, hypersensitivity to food, underweight, and
            
203

    
overweight; uses for supplying a particular dietary need which exist by reason of age including
            
204

    
but not limited to the ages of infancy and childbirth, and also uses for supplementing and for
            
205

    
fortifying the ordinary or unusual diet with any vitamin, mineral, or other dietary property for
            
206

    
use of a food.  Any particular use of a food is a special dietary use regardless of the nutritional
            
207

    
purposes.
            
208

    
    (u)  "Immediate precursor" means a substance which the Attorney General of the United
            
209

    
States has found to be, and by regulation designated as being, the principal compound used or
            
210

    
produced primarily for use in the manufacture of a controlled substance, or which is an
            
211

    
immediate chemical intermediary used or likely to be used in the manufacture of a controlled
            
212

    
substance, the control of which is necessary to prevent, curtail, or limit the manufacture of the
            
213

    
controlled substance.

            
214


    
    (v)  "Indian" means a member of an Indian tribe.
            
215

    
    (w)  "Indian religion" means any religion:
            
216

    
    (i)  the origin and interpretation of which is from within a traditional Indian culture or
            
217

    
community; and
            
218

    
    (ii)  which is practiced by Indians.
            
219

    
    (x)  "Indian tribe" means any tribe, band, nation, pueblo, or other organized group or
            
220

    
community of Indians, including any Alaska Native village, which is recognized as eligible for
            
221

    
the special programs and services provided by the United States to Indians because of their
            
222

    
status as Indians.
            
223

    
    [(v)] (y)  "Manufacture" means the production, preparation, propagation, compounding,
            
224

    
or processing of a controlled substance, either directly or indirectly by extraction from
            
225

    
substances of natural origin, or independently by means of chemical synthesis or by a
            
226

    
combination of extraction and chemical synthesis.
            
227

    
    [(w)] (z)  "Manufacturer" includes any person who packages, repackages, or labels any
            
228

    
container of any controlled substance, except pharmacists who dispense or compound
            
229

    
prescription orders for delivery to the ultimate consumer.
            
230

    
    [(x)] (aa)  "Marijuana" means all species of the genus cannabis and all parts of the
            
231

    
genus, whether growing or not; the seeds of it; the resin extracted from any part of the plant;
            
232

    
and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its
            
233

    
seeds, or resin.  The term does not include the mature stalks of the plant, fiber produced from
            
234

    
the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt,
            
235

    
derivative, mixture, or preparation of the mature stalks, except the resin extracted from them,
            
236

    
fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination.  Any
            
237

    
synthetic equivalents of the substances contained in the plant cannabis sativa or any other
            
238

    
species of the genus cannabis which are chemically indistinguishable and pharmacologically
            
239

    
active are also included.
            
240

    
    [(y)] (bb)  "Money" means officially issued coin and currency of the United States or
            
241

    
any foreign country.
            
242

    
    [(z)] (cc)  "Narcotic drug" means any of the following, whether produced directly or
            
243

    
indirectly by extraction from substances of vegetable origin, or independently by means of
            
244

    
chemical synthesis, or by a combination of extraction and chemical synthesis:

            
245


    
    (i)  opium, coca leaves, and opiates;
            
246

    
    (ii)  a compound, manufacture, salt, derivative, or preparation of opium, coca leaves, or
            
247

    
opiates;
            
248

    
    (iii)  opium poppy and poppy straw; or
            
249

    
    (iv)  a substance, and any compound, manufacture, salt, derivative, or preparation of the
            
250

    
substance, which is chemically identical with any of the substances referred to in Subsection
            
251

    
(1)[(z)](cc)(i), (ii), or (iii), except narcotic drug does not include decocainized coca leaves or
            
252

    
extracts of coca leaves which do not contain cocaine or ecgonine.
            
253

    
    [(aa)] (dd)  "Negotiable instrument" means documents, containing an unconditional
            
254

    
promise to pay a sum of money, which are legally transferable to another party by endorsement
            
255

    
or delivery.
            
256

    
    [(bb)] (ee)  "Opiate" means any drug or other substance having an addiction-forming or
            
257

    
addiction-sustaining liability similar to morphine or being capable of conversion into a drug
            
258

    
having addiction-forming or addiction-sustaining liability.
            
259

    
    [(cc)] (ff)  "Opium poppy" means the plant of the species papaver somniferum L.,
            
260

    
except the seeds of the plant.
            
261

    
    [(dd)] (gg)  "Person" means any corporation, association, partnership, trust, other
            
262

    
institution or entity or one or more individuals.
            
263

    
    [(ee)] (hh)  "Poppy straw" means all parts, except the seeds, of the opium poppy, after
            
264

    
mowing.
            
265

    
    [(ff)] (ii)  "Possession" or "use" means the joint or individual ownership, control,
            
266

    
occupancy, holding, retaining, belonging, maintaining, or the application, inhalation,
            
267

    
swallowing, injection, or consumption, as distinguished from distribution, of controlled
            
268

    
substances and includes individual, joint, or group possession or use of controlled substances. 
            
269

    
For a person to be a possessor or user of a controlled substance, it is not required that he be
            
270

    
shown to have individually possessed, used, or controlled the substance, but it is sufficient if it
            
271

    
is shown that the person jointly participated with one or more persons in the use, possession, or
            
272

    
control of any substances with knowledge that the activity was occurring, or the controlled
            
273

    
substance is found in a place or under circumstances indicating that the person had the ability
            
274

    
and the intent to exercise dominion and control over it.
            
275

    
    [(gg)] (jj)  "Practitioner" means a physician, dentist, veterinarian, pharmacist, scientific

            
276


    
investigator, pharmacy, hospital, or other person licensed, registered, or otherwise permitted to
            
277

    
distribute, dispense, conduct research with respect to, administer, or use in teaching or
            
278

    
chemical analysis a controlled substance in the course of professional practice or research in
            
279

    
this state.
            
280

    
    [(hh)] (kk)  "Prescribe" means to issue a prescription orally or in writing.
            
281

    
    [(ii)] (ll)  "Prescription" means an order issued by a licensed practitioner, in the course
            
282

    
of that practitioner's professional practice, for a controlled substance, other drug, or device
            
283

    
which it dispenses or administers for use by a patient or an animal.  The order may be issued by
            
284

    
word of mouth, written document, telephone, facsimile transmission, computer, or other
            
285

    
electronic means of communication as defined by rule.
            
286

    
    [(jj)] (mm)  "Production" means the manufacture, planting, cultivation, growing, or
            
287

    
harvesting of a controlled substance.
            
288

    
    [(kk)] (nn)  "Securities" means any stocks, bonds, notes, or other evidences of debt or of
            
289

    
property.
            
290

    
    [(ll)] (oo)  "State" means the state of Utah.
            
291

    
    [(mm)] (pp)  "Ultimate user" means any person who lawfully possesses a controlled
            
292

    
substance for his own use, for the use of a member of his household, or for administration to an
            
293

    
animal owned by him or a member of his household.
            
294

    
    (2)  If a term used in this chapter is not defined, the definition and terms of Title 76,
            
295

    
Utah Criminal Code, shall apply.
            
296

    
    Section 3.  
Section  
58-37-4

 is amended to read:
            
297

    
     58-37-4.  Schedules of controlled substances -- Schedules I through V -- Findings
            
298

    
 required -- Specific substances included in schedules.
            
299

    
    (1)  There are established five schedules of controlled substances known as Schedules I,
            
300

    
II, III, IV, and V which shall consist of substances listed in this section.
            
301

    
    (2)  Schedules I, II, III, IV, and V consist of the following drugs or other substances by
            
302

    
the official name, common or usual name, chemical name, or brand name designated:
            
303

    
    (a)  Schedule I:
            
304

    
    (i)  Unless specifically excepted or unless listed in another schedule, any of the
            
305

    
following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
            
306

    
ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific

            
307


    
chemical designation:
            
308

    
    (A)  Acetyl-alpha-methylfentanyl
            
309

    
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
            
310

    
    (B)  Acetylmethadol;
            
311

    
    (C)  Allylprodine;
            
312

    
    (D)  Alphacetylmethadol, except levo-alphacetylmethadol also known as
            
313

    
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
            
314

    
    (E)  Alphameprodine;
            
315

    
    (F)  Alphamethadol;
            
316

    
    (G)  Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
            
317

    
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N_propanilido) piperidine);
            
318

    
    (H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
            
319

    
piperidinyl]-N-phenylpropanamide);
            
320

    
    (I)  Benzethidine;
            
321

    
    (J)  Betacetylmethadol;
            
322

    
    (K)  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
            
323

    
piperidinyl]-N-phenylpropanamide);
            
324

    
    (L)  Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
            
325

    
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
            
326

    
    (M)  Betameprodine;
            
327

    
    (N)  Betamethadol;
            
328

    
    (O)  Betaprodine;
            
329

    
    (P)  Clonitazene;
            
330

    
    (Q)  Dextromoramide;
            
331

    
    (R)  Diampromide;
            
332

    
    (S)  Diethylthiambutene;
            
333

    
    (T)  Difenoxin;
            
334

    
    (U)  Dimenoxadol;
            
335

    
    (V)  Dimepheptanol;
            
336

    
    (W)  Dimethylthiambutene;
            
337

    
    (X)  Dioxaphetyl butyrate;

            
338


    
    (Y)  Dipipanone;
            
339

    
    (Z)  Ethylmethylthiambutene;
            
340

    
    (AA)  Etonitazene;
            
341

    
    (BB)  Etoxeridine;
            
342

    
    (CC)  Furethidine;
            
343

    
    (DD)  Hydroxypethidine;
            
344

    
    (EE)  Ketobemidone;
            
345

    
    (FF)  Levomoramide;
            
346

    
    (GG)  Levophenacylmorphan;
            
347

    
    (HH)  Morpheridine;
            
348

    
    (II)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
            
349

    
    (JJ)  Noracymethadol;
            
350

    
    (KK)  Norlevorphanol;
            
351

    
    (LL)  Normethadone;
            
352

    
    (MM)  Norpipanone;
            
353

    
    (NN)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
            
354

    
propanamide;
            
355

    
    (OO)  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
            
356

    
    (PP)  Phenadoxone;
            
357

    
    (QQ)  Phenampromide;
            
358

    
    (RR)  Phenomorphan;
            
359

    
    (SS)  Phenoperidine;
            
360

    
    (TT)  Piritramide;
            
361

    
    (UU)  Proheptazine;
            
362

    
    (VV)  Properidine;
            
363

    
    (WW)  Propiram;
            
364

    
    (XX)  Racemoramide;
            
365

    
    (YY)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
            
366

    
    (ZZ)  Tilidine;
            
367

    
    (AAA)  Trimeperidine;
            
368

    
    (BBB)  3-methylfentanyl, including the optical and geometric isomers

            
369


    
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
            
370

    
    (CCC)  3-methylthiofentanyl
            
371

    
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
            
372

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any of the
            
373

    
following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
            
374

    
salts, isomers, and salts of isomers is possible within the specific chemical designation:
            
375

    
    (A)  Acetorphine;
            
376

    
    (B)  Acetyldihydrocodeine;
            
377

    
    (C)  Benzylmorphine;
            
378

    
    (D)  Codeine methylbromide;
            
379

    
    (E)  Codeine-N-Oxide;
            
380

    
    (F)  Cyprenorphine;
            
381

    
    (G)  Desomorphine;
            
382

    
    (H)  Dihydromorphine;
            
383

    
    (I)  Drotebanol;
            
384

    
    (J)  Etorphine (except hydrochloride salt);
            
385

    
    (K)  Heroin;
            
386

    
    (L)  Hydromorphinol;
            
387

    
    (M)  Methyldesorphine;
            
388

    
    (N)  Methylhydromorphine;
            
389

    
    (O)  Morphine methylbromide;
            
390

    
    (P)  Morphine methylsulfonate;
            
391

    
    (Q)  Morphine-N-Oxide;
            
392

    
    (R)  Myrophine;
            
393

    
    (S)  Nicocodeine;
            
394

    
    (T)  Nicomorphine;
            
395

    
    (U)  Normorphine;
            
396

    
    (V)  Pholcodine; and
            
397

    
    (W)  Thebacon.
            
398

    
    (iii)  Unless specifically excepted or unless listed in another schedule, any material,
            
399

    
compound, mixture, or preparation which contains any quantity of the following hallucinogenic

            
400


    
substances, or which contains any of their salts, isomers, and salts of isomers when the
            
401

    
existence of the salts, isomers, and salts of isomers is possible within the specific chemical
            
402

    
designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
            
403

    
geometric isomers:
            
404

    
    (A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
            
405

    
.-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
            
406

    
    (B)  4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
            
407

    
4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
            
408

    
    (C)  4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
            
409

    
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
            
410

    
    (D)  2,5-dimethoxyamphetamine, some trade or other names:
            
411

    
2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
            
412

    
    (E)  2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
            
413

    
    (F)  4-methoxyamphetamine, some trade or other names:
            
414

    
4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
            
415

    
    (G)  5-methoxy-3,4-methylenedioxyamphetamine;
            
416

    
    (H)  4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
            
417

    
4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
            
418

    
    (I)  3,4-methylenedioxy amphetamine;
            
419

    
    (J)  3,4-methylenedioxymethamphetamine (MDMA);
            
420

    
    (K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
            
421

    
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
            
422

    
    (L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as
            
423

    
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
            
424

    
    (M)  3,4,5-trimethoxy amphetamine;
            
425

    
    (N)  Bufotenine, some trade and other names:
            
426

    
3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
            
427

    
N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
            
428

    
    (O)  Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
            
429

    
    (P)  Dimethyltryptamine, some trade or other names: DMT;
            
430

    
    (Q)  Ibogaine, some trade and other names:

            
431


    
7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
            
432

    
[5,4-b] indole; Tabernanthe iboga;
            
433

    
    (R)  Lysergic acid diethylamide;
            
434

    
    (S)  Marijuana;
            
435

    
    (T)  Mescaline;
            
436

    
    (U)  Parahexyl, some trade or other names:
            
437

    
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
            
438

    
    (V)  Peyote, meaning all parts of the plant presently classified botanically as
            
439

    
Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
            
440

    
any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
            
441

    
preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
            
442

    
    (W)  N-ethyl-3-piperidyl benzilate;
            
443

    
    (X)  N-methyl-3-piperidyl benzilate;
            
444

    
    (Y)  Psilocybin;
            
445

    
    (Z)  Psilocyn;
            
446

    
    (AA)  Tetrahydrocannabinols, synthetic equivalents of the substances contained in the
            
447

    
plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
            
448

    
and their isomers with similar chemical structure and pharmacological activity such as the
            
449

    
following: .1 cis or trans tetrahydrocannabinol, and their optical isomers  .6 cis or trans
            
450

    
tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
            
451

    
optical isomers, and since nomenclature of these substances is not internationally standardized,
            
452

    
compounds of these structures, regardless of numerical designation of atomic positions
            
453

    
covered;
            
454

    
    (BB)  Ethylamine analog of phencyclidine, some trade or other names:
            
455

    
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
            
456

    
N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
            
457

    
    (CC)  Pyrrolidine analog of phencyclidine, some trade or other names:
            
458

    
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
            
459

    
    (DD)  Thiophene analog of phencyclidine, some trade or other names:
            
460

    
1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
            
461

    
    (EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.

            
462


    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material
            
463

    
compound, mixture, or preparation which contains any quantity of the following substances
            
464

    
having a depressant effect on the central nervous system, including its salts, isomers, and salts
            
465

    
of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
            
466

    
specific chemical designation:
            
467

    
    (A)  Mecloqualone; and
            
468

    
    (B)  Methaqualone.
            
469

    
    (v)  Any material, compound, mixture, or preparation containing any quantity of the
            
470

    
following substances having a stimulant effect on the central nervous system, including their
            
471

    
salts, isomers, and salts of isomers:
            
472

    
    (A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
            
473

    
4,5-dihydro-5-phenyl-2-oxazolamine;
            
474

    
    (B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
            
475

    
alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
            
476

    
    (C)  Fenethylline;
            
477

    
    (D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;
            
478

    
alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
            
479

    
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
            
480

    
methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
            
481

    
optical isomers;
            
482

    
    (E)  (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
            
483

    
    (F)  N-ethylamphetamine; and
            
484

    
    (G)  N,N-dimethylamphetamine, also known as
            
485

    
N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
            
486

    
    (vi)  Any material, compound, mixture, or preparation which contains any quantity of
            
487

    
the following substances, including their optical isomers, salts, and salts of isomers, subject to
            
488

    
temporary emergency scheduling:
            
489

    
    (A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
            
490

    
    (B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
            
491

    
    (vii)  Unless specifically excepted or unless listed in another schedule, any material,
            
492

    
compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate

            
493


    
(gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
            
494

    
    (b)  Schedule II:
            
495

    
    (i)  Unless specifically excepted or unless listed in another schedule, any of the
            
496

    
following substances whether produced directly or indirectly by extraction from substances of
            
497

    
vegetable origin, or independently by means of chemical synthesis, or by a combination of
            
498

    
extraction and chemical synthesis:
            
499

    
    (A)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or
            
500

    
opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
            
501

    
and their respective salts, but including:
            
502

    
    (I)  Raw opium;
            
503

    
    (II)  Opium extracts;
            
504

    
    (III)  Opium fluid;
            
505

    
    (IV)  Powdered opium;
            
506

    
    (V)  Granulated opium;
            
507

    
    (VI)  Tincture of opium;
            
508

    
    (VII)  Codeine;
            
509

    
    (VIII)  Ethylmorphine;
            
510

    
    (IX)  Etorphine hydrochloride;
            
511

    
    (X)  Hydrocodone;
            
512

    
    (XI)  Hydromorphone;
            
513

    
    (XII)  Metopon;
            
514

    
    (XIII)  Morphine;
            
515

    
    (XIV)  Oxycodone;
            
516

    
    (XV)  Oxymorphone; and
            
517

    
    (XVI)  Thebaine;
            
518

    
    (B)  Any salt, compound, derivative, or preparation which is chemically equivalent or
            
519

    
identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
            
520

    
substances may not include the isoquinoline alkaloids of opium;
            
521

    
    (C)  Opium poppy and poppy straw;
            
522

    
    (D)  Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
            
523

    
any salt, compound, derivative, or preparation which is chemically equivalent or identical with

            
524


    
any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
            
525

    
and salts of isomers and derivatives, whether derived from the coca plant or synthetically
            
526

    
produced, except the substances may not include decocainized coca leaves or extraction of coca
            
527

    
leaves, which extractions do not contain cocaine or ecgonine; and
            
528

    
    (E)  Concentrate of poppy straw, which means the crude extract of poppy straw in either
            
529

    
liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
            
530

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any of the
            
531

    
following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
            
532

    
ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
            
533

    
chemical designation, except dextrorphan and levopropoxyphene:
            
534

    
    (A)  Alfentanil;
            
535

    
    (B)  Alphaprodine;
            
536

    
    (C)  Anileridine;
            
537

    
    (D)  Bezitramide;
            
538

    
    (E)  Bulk dextropropoxyphene (nondosage forms);
            
539

    
    (F)  Carfentanil;
            
540

    
    (G)  Dihydrocodeine;
            
541

    
    (H)  Diphenoxylate;
            
542

    
    (I)  Fentanyl;
            
543

    
    (J)  Isomethadone;
            
544

    
    (K)  Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
            
545

    
levomethadyl acetate, or LAAM;
            
546

    
    (L)  Levomethorphan;
            
547

    
    (M)  Levorphanol;
            
548

    
    (N)  Metazocine;
            
549

    
    (O)  Methadone;
            
550

    
    (P)  Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
            
551

    
    (Q)  Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
            
552

    
acid;
            
553

    
    (R)  Pethidine (meperidine);
            
554

    
    (S)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;

            
555


    
    (T)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
            
556

    
    (U)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
            
557

    
    (V)  Phenazocine;
            
558

    
    (W)  Piminodine;
            
559

    
    (X)  Racemethorphan;
            
560

    
    (Y)  Racemorphan;
            
561

    
    (Z)  Remifentanil; and
            
562

    
    (AA)  Sufentanil.
            
563

    
    (iii)  Unless specifically excepted or unless listed in another schedule, any material,
            
564

    
compound, mixture, or preparation which contains any quantity of the following substances
            
565

    
having a stimulant effect on the central nervous system:
            
566

    
    (A)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;
            
567

    
    (B)  Methamphetamine, its salts, isomers, and salts of its isomers;
            
568

    
    (C)  Phenmetrazine and its salts; and
            
569

    
    (D)  Methylphenidate.
            
570

    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material,
            
571

    
compound, mixture, or preparation which contains any quantity of the following substances
            
572

    
having a depressant effect on the central nervous system, including its salts, isomers, and salts
            
573

    
of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
            
574

    
specific chemical designation:
            
575

    
    (A)  Amobarbital;
            
576

    
    (B)  Glutethimide;
            
577

    
    (C)  Pentobarbital;
            
578

    
    (D)  Phencyclidine;
            
579

    
    (E)  Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
            
580

    
1-piperidinocyclohexanecarbonitrile (PCC); and
            
581

    
    (F)  Secobarbital.
            
582

    
    (v)  Unless specifically excepted or unless listed in another schedule, any material,
            
583

    
compound, mixture, or preparation which contains any quantity of Phenylacetone.
            
584

    
    Some of these substances may be known by trade or other names: phenyl-2-propanone,
            
585

    
P2P; benzyl methyl ketone, methyl benzyl ketone.

            
586


    
    (vi)  Nabilone, another name for nabilone:
            
587

    
(.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
            
588

    
6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
            
589

    
    (c)  Schedule III:
            
590

    
    (i)  Unless specifically excepted or unless listed in another schedule, any material,
            
591

    
compound, mixture, or preparation which contains any quantity of the following substances
            
592

    
having a stimulant effect on the central nervous system, including its salts, isomers whether
            
593

    
optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
            
594

    
and salts of isomers is possible within the specific chemical designation:
            
595

    
    (A)  Those compounds, mixtures, or preparations in dosage unit form containing any
            
596

    
stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
            
597

    
listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
            
598

    
Code of Federal Regulations, and any other drug of the quantitive composition shown in that
            
599

    
list for those drugs or which is the same except that it contains a lesser quantity of controlled
            
600

    
substances;
            
601

    
    (B)  Benzphetamine;
            
602

    
    (C)  Chlorphentermine;
            
603

    
    (D)  Clortermine; and
            
604

    
    (E)  Phendimetrazine.
            
605

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any material,
            
606

    
compound, mixture, or preparation which contains any quantity of the following substances
            
607

    
having a depressant effect on the central nervous system:
            
608

    
    (A)  Any compound, mixture, or preparation containing amobarbital, secobarbital,
            
609

    
pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
            
610

    
which are not listed in any schedule;
            
611

    
    (B)  Any suppository dosage form containing amobarbital, secobarbital, or
            
612

    
pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
            
613

    
Administration for marketing only as a suppository;
            
614

    
    (C)  Any substance which contains any quantity of a derivative of barbituric acid or any
            
615

    
salt of any of them;
            
616

    
    (D)  Chlorhexadol;

            
617


    
    (E)  Buprenorphine;
            
618

    
    (F)  Any drug product containing gamma hydroxybutyric acid, including its salts,
            
619

    
isomers, and salts of isomers, for which an application is approved under the federal Food,
            
620

    
Drug, and Cosmetic Act, Section 505;
            
621

    
    (G)  Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
            
622

    
. -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone[.];
            
623

    
    (H)  Lysergic acid;
            
624

    
    (I)  Lysergic acid amide;
            
625

    
    (J)  Methyprylon;
            
626

    
    (K)  Sulfondiethylmethane;
            
627

    
    (L)  Sulfonethylmethane;
            
628

    
    (M)  Sulfonmethane; and
            
629

    
    (N)  Tiletamine and zolazepam or any of their salts, some trade or other names for a
            
630

    
tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
            
631

    
2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
            
632

    
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
            
633

    
flupyrazapon.
            
634

    
    (iii)  Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
            
635

    
U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
            
636

    
(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
            
637

    
(-)-delta-9-(trans)-tetrahydrocannabinol.
            
638

    
    (iv)  Nalorphine.
            
639

    
    (v)  Unless specifically excepted or unless listed in another schedule, any material,
            
640

    
compound, mixture, or preparation containing limited quantities of any of the following
            
641

    
narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
            
642

    
    (A)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
            
643

    
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
            
644

    
opium;
            
645

    
    (B)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
            
646

    
milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
            
647

    
therapeutic amounts;

            
648


    
    (C)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
            
649

    
than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
            
650

    
alkaloid of opium;
            
651

    
    (D)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
            
652

    
than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
653

    
recognized therapeutic amounts;
            
654

    
    (E)  Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
            
655

    
milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
            
656

    
therapeutic amounts;
            
657

    
    (F)  Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
            
658

    
than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
659

    
recognized therapeutic amounts;
            
660

    
    (G)  Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
            
661

    
more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
662

    
recognized therapeutic amounts; and
            
663

    
    (H)  Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
            
664

    
one or more active, non-narcotic ingredients in recognized therapeutic amounts.
            
665

    
    (vi)  Unless specifically excepted or unless listed in another schedule, anabolic steroids
            
666

    
including any of the following or any isomer, ester, salt, or derivative of the following that
            
667

    
promotes muscle growth:
            
668

    
    (A)  Boldenone;
            
669

    
    (B)  Chlorotestosterone (4-chlortestosterone);
            
670

    
    (C)  Clostebol;
            
671

    
    (D)  Dehydrochlormethyltestosterone;
            
672

    
    (E)  Dihydrotestosterone (4-dihydrotestosterone);
            
673

    
    (F)  Drostanolone;
            
674

    
    (G)  Ethylestrenol;
            
675

    
    (H)  Fluoxymesterone;
            
676

    
    (I)  Formebulone (formebolone);
            
677

    
    (J)  Mesterolone;
            
678

    
    (K)  Methandienone;

            
679


    
    (L)  Methandranone;
            
680

    
    (M)  Methandriol;
            
681

    
    (N)  Methandrostenolone;
            
682

    
    (O)  Methenolone;
            
683

    
    (P)  Methyltestosterone;
            
684

    
    (Q)  Mibolerone;
            
685

    
    (R)  Nandrolone;
            
686

    
    (S)  Norethandrolone;
            
687

    
    (T)  Oxandrolone;
            
688

    
    (U)  Oxymesterone;
            
689

    
    (V)  Oxymetholone;
            
690

    
    (W)  Stanolone;
            
691

    
    (X)  Stanozolol;
            
692

    
    (Y)  Testolactone;
            
693

    
    (Z)  Testosterone; and
            
694

    
    (AA)  Trenbolone.
            
695

    
    Anabolic steroids expressly intended for administration through implants to cattle or
            
696

    
other nonhuman species, and approved by the Secretary of Health and Human Services for use,
            
697

    
may not be classified as a controlled substance.
            
698

    
    (d)  Schedule IV:
            
699

    
    (i)  Unless specifically excepted or unless listed in another schedule, any material,
            
700

    
compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
            
701

    
less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
            
702

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any material,
            
703

    
compound, mixture, or preparation which contains any quantity of the following substances,
            
704

    
including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
            
705

    
salts of isomers is possible within the specific chemical designation:
            
706

    
    (A)  Alprazolam;
            
707

    
    (B)  Barbital;
            
708

    
    (C)  Bromazepam;
            
709

    
    (D)  Butorphanol;

            
710


    
    (E)  Camazepam;
            
711

    
    (F)  Chloral betaine;
            
712

    
    (G)  Chloral hydrate;
            
713

    
    (H)  Chlordiazepoxide;
            
714

    
    (I)  Clobazam;
            
715

    
    (J)  Clonazepam;
            
716

    
    (K)  Clorazepate;
            
717

    
    (L)  Clotiazepam;
            
718

    
    (M)  Cloxazolam;
            
719

    
    (N)  Delorazepam;
            
720

    
    (O)  Diazepam;
            
721

    
    (P)  Dichloralphenazone;
            
722

    
    (Q)  Estazolam;
            
723

    
    (R)  Ethchlorvynol;
            
724

    
    (S)  Ethinamate;
            
725

    
    (T)  Ethyl loflazepate;
            
726

    
    (U)  Fludiazepam;
            
727

    
    (V)  Flunitrazepam;
            
728

    
    (W)  Flurazepam;
            
729

    
    (X)  Halazepam;
            
730

    
    (Y)  Haloxazolam;
            
731

    
    (Z)  Ketazolam;
            
732

    
    (AA)  Loprazolam;
            
733

    
    (BB)  Lorazepam;
            
734

    
    (CC)  Lormetazepam;
            
735

    
    (DD)  Mebutamate;
            
736

    
    (EE)  Medazepam;
            
737

    
    (FF)  Meprobamate;
            
738

    
    (GG)  Methohexital;
            
739

    
    (HH)  Methylphenobarbital (mephobarbital);
            
740

    
    (II)  Midazolam;

            
741


    
    (JJ)  Nimetazepam;
            
742

    
    (KK)  Nitrazepam;
            
743

    
    (LL)  Nordiazepam;
            
744

    
    (MM)  Oxazepam;
            
745

    
    (NN)  Oxazolam;
            
746

    
    (OO)  Paraldehyde;
            
747

    
    (PP)  Pentazocine;
            
748

    
    (QQ)  Petrichloral;
            
749

    
    (RR)  Phenobarbital;
            
750

    
    (SS)  Pinazepam;
            
751

    
    (TT)  Prazepam;
            
752

    
    (UU)  Quazepam;
            
753

    
    (VV)  Temazepam;
            
754

    
    (WW)  Tetrazepam;
            
755

    
    (XX)  Triazolam;
            
756

    
    (YY)  Zaleplon; and
            
757

    
    (ZZ)  Zolpidem.
            
758

    
    (iii)  Any material, compound, mixture, or preparation of fenfluramine which contains
            
759

    
any quantity of the following substances, including its salts, isomers whether optical, position,
            
760

    
or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
            
761

    
isomers is possible.
            
762

    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material,
            
763

    
compound, mixture, or preparation which contains any quantity of the following substances
            
764

    
having a stimulant effect on the central nervous system, including its salts, isomers whether
            
765

    
optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
            
766

    
isomers, and salts of isomers is possible within the specific chemical designation:
            
767

    
    (A)  Cathine ((+)-norpseudoephedrine);
            
768

    
    (B)  Diethylpropion;
            
769

    
    (C)  Fencamfamine;
            
770

    
    (D)  Fenproprex;
            
771

    
    (E)  Mazindol;

            
772


    
    (F)  Mefenorex;
            
773

    
    (G)  Modafinil;
            
774

    
    (H)  Pemoline, including organometallic complexes and chelates thereof;
            
775

    
    (I)  Phentermine;
            
776

    
    (J)  Pipradrol;
            
777

    
    (K)  Sibutramine; and
            
778

    
    (L)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).
            
779

    
    (v)  Unless specifically excepted or unless listed in another schedule, any material,
            
780

    
compound, mixture, or preparation which contains any quantity of dextropropoxyphene
            
781

    
(alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
            
782

    
    (e)  Schedule V: Any compound, mixture, or preparation containing any of the
            
783

    
following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
            
784

    
base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
            
785

    
sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
            
786

    
qualities other than those possessed by the narcotic drug alone:
            
787

    
    (i)  not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
            
788

    
    (ii)  not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
            
789

    
grams;
            
790

    
    (iii)  not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
            
791

    
grams;
            
792

    
    (iv)  not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
            
793

    
atropine sulfate per dosage unit;
            
794

    
    (v)  not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
            
795

    
    (vi)  not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
            
796

    
atropine sulfate per dosage unit; and
            
797

    
    (vii)  unless specifically exempted or excluded or unless listed in another schedule, any
            
798

    
material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
            
799

    
effect on the central nervous system, including its salts, isomers, and salts of isomers.
            
800

    
    Section 4.  
Section  
58-37-8

 is amended to read:
            
801

    
     58-37-8.  Prohibited acts -- Penalties.
            
802

    
    (1)  Prohibited acts A -- Penalties:

            
803


    
    (a)  Except as authorized by this chapter, it is unlawful for any person to knowingly and
            
804

    
intentionally:
            
805

    
    (i)  produce, manufacture, or dispense, or to possess with intent to produce,
            
806

    
manufacture, or dispense, a controlled or counterfeit substance;
            
807

    
    (ii)  distribute a controlled or counterfeit substance, or to agree, consent, offer, or
            
808

    
arrange to distribute a controlled or counterfeit substance;
            
809

    
    (iii)  possess a controlled or counterfeit substance with intent to distribute; or
            
810

    
    (iv)  engage in a continuing criminal enterprise where:
            
811

    
    (A)  the person participates, directs, or engages in conduct which results in any
            
812

    
violation of any provision of Title 58, Chapters 37, 37a, 37b, 37c, or 37d that is a felony; and
            
813

    
    (B)  the violation is a part of a continuing series of two or more violations of Title 58,
            
814

    
Chapters 37, 37a, 37b, 37c, or 37d on separate occasions that are undertaken in concert with
            
815

    
five or more persons with respect to whom the person occupies a position of organizer,
            
816

    
supervisor, or any other position of management.
            
817

    
    (b)  Any person convicted of violating Subsection (1)(a) with respect to:
            
818

    
    (i)  a substance classified in Schedule I or II, a controlled substance analog, or
            
819

    
gammahydroxybutyric acid as listed in Schedule III is guilty of a second degree felony and
            
820

    
upon a second or subsequent conviction is guilty of a first degree felony;
            
821

    
    (ii)  a substance classified in Schedule III or IV, or marijuana, is guilty of a third degree
            
822

    
felony, and upon a second or subsequent conviction is guilty of a second degree felony; or
            
823

    
    (iii)  a substance classified in Schedule V is guilty of a class A misdemeanor and upon a
            
824

    
second or subsequent conviction is guilty of a third degree felony.
            
825

    
    (c)  Any person who has been convicted of a violation of Subsection (1)(a)(ii) or (iii)
            
826

    
may be sentenced to imprisonment for an indeterminate term as provided by law, but if the trier
            
827

    
of fact finds a firearm as defined in Section 

76-10-501

 was used, carried, or possessed on his
            
828

    
person or in his immediate possession during the commission or in furtherance of the offense,
            
829

    
the court shall additionally sentence the person convicted for a term of one year to run
            
830

    
consecutively and not concurrently; and the court may additionally sentence the person
            
831

    
convicted for an indeterminate term not to exceed five years to run consecutively and not
            
832

    
concurrently.
            
833

    
    (d)  Any person convicted of violating Subsection (1)(a)(iv) is guilty of a first degree

            
834


    
felony punishable by imprisonment for an indeterminate term of not less than seven years and
            
835

    
which may be for life.  Imposition or execution of the sentence may not be suspended, and the
            
836

    
person is not eligible for probation.
            
837

    
    (2)  Prohibited acts B -- Penalties:
            
838

    
    (a)  It is unlawful:
            
839

    
    (i)  for any person knowingly and intentionally to possess or use a controlled substance
            
840

    
analog or a controlled substance, unless it was obtained under a valid prescription or order,
            
841

    
directly from a practitioner while acting in the course of his professional practice, or as
            
842

    
otherwise authorized by this chapter;
            
843

    
    (ii)  for any owner, tenant, licensee, or person in control of any building, room,
            
844

    
tenement, vehicle, boat, aircraft, or other place knowingly and intentionally to permit them to
            
845

    
be occupied by persons unlawfully possessing, using, or distributing controlled substances in
            
846

    
any of those locations; or
            
847

    
    (iii)  for any person knowingly and intentionally to possess an altered or forged
            
848

    
prescription or written order for a controlled substance.
            
849

    
    (b)  Any person convicted of violating Subsection (2)(a)(i) with respect to:
            
850

    
    (i)  marijuana, if the amount is 100 pounds or more, is guilty of a second degree felony;
            
851

    
    (ii)  a substance classified in Schedule I or II, marijuana, if the amount is more than 16
            
852

    
ounces, but less than 100 pounds, or a controlled substance analog, is guilty of a third degree
            
853

    
felony; or
            
854

    
    (iii)  marijuana, if the marijuana is not in the form of an extracted resin from any part of
            
855

    
the plant, and the amount is more than one ounce but less than 16 ounces, is guilty of a class A
            
856

    
misdemeanor.
            
857

    
    (c)  Upon a person's conviction of a violation of this Subsection (2) subsequent to a
            
858

    
conviction under Subsection (1)(a), that person shall be sentenced to a one degree greater
            
859

    
penalty than provided in this Subsection (2).
            
860

    
    (d)  Any person who violates Subsection (2)(a)(i) with respect to all other controlled
            
861

    
substances not included in Subsection (2)(b)(i), (ii), or (iii), including less than one ounce of
            
862

    
marijuana, is guilty of a class B misdemeanor.  Upon a second conviction the person is guilty
            
863

    
of a class A misdemeanor, and upon a third or subsequent conviction the person is guilty of a
            
864

    
third degree felony.

            
865


    
    (e)  Any person convicted of violating Subsection (2)(a)(i) while inside the exterior
            
866

    
boundaries of property occupied by any correctional facility as defined in Section 

64-13-1

 or
            
867

    
any public jail or other place of confinement shall be sentenced to a penalty one degree greater
            
868

    
than provided in Subsection (2)(b), and if the conviction is with respect to controlled
            
869

    
substances as listed in:
            
870

    
    (i)  Subsection (2)(b), the person may be sentenced to imprisonment for an
            
871

    
indeterminate term as provided by law, and:
            
872

    
    (A)  the court shall additionally sentence the person convicted to a term of one year to
            
873

    
run consecutively and not concurrently; and
            
874

    
    (B)  the court may additionally sentence the person convicted for an indeterminate term
            
875

    
not to exceed five years to run consecutively and not concurrently; and
            
876

    
    (ii)  Subsection (2)(d), the person may be sentenced to imprisonment for an
            
877

    
indeterminate term as provided by law, and the court shall additionally sentence the person
            
878

    
convicted to a term of six months to run consecutively and not concurrently.
            
879

    
    (f)  Any person convicted of violating Subsection (2)(a)(ii) or (2)(a)(iii) is:
            
880

    
    (i)  on a first conviction, guilty of a class B misdemeanor;
            
881

    
    (ii)  on a second conviction, guilty of a class A misdemeanor; and
            
882

    
    (iii)  on a third or subsequent conviction, guilty of a third degree felony.
            
883

    
    (g)  A person is subject to the penalties under Subsection (4)(c) who, in an offense not
            
884

    
amounting to a violation of Section 

76-5-207

:
            
885

    
    (i)  violates Subsection (2)(a)(i) by knowingly and intentionally having in his body any
            
886

    
measurable amount of a controlled substance; and
            
887

    
    (ii)  operates a motor vehicle as defined in Section 

76-5-207

 in a negligent manner,
            
888

    
causing serious bodily injury as defined in Section 

76-1-601

 or the death of another.
            
889

    
    (3)  Prohibited acts C -- Penalties:
            
890

    
    (a)  It is unlawful for any person knowingly and intentionally:
            
891

    
    (i)  to use in the course of the manufacture or distribution of a controlled substance a
            
892

    
license number which is fictitious, revoked, suspended, or issued to another person or, for the
            
893

    
purpose of obtaining a controlled substance, to assume the title of, or represent himself to be, a
            
894

    
manufacturer, wholesaler, apothecary, physician, dentist, veterinarian, or other authorized
            
895

    
person;

            
896


    
    (ii)  to acquire or obtain possession of, to procure or attempt to procure the
            
897

    
administration of, to obtain a prescription for, to prescribe or dispense to any person known to
            
898

    
be attempting to acquire or obtain possession of, or to procure the administration of any
            
899

    
controlled substance by misrepresentation or failure by the person to disclose his receiving any
            
900

    
controlled substance from another source, fraud, forgery, deception, subterfuge, alteration of a
            
901

    
prescription or written order for a controlled substance, or the use of a false name or address;
            
902

    
    (iii)  to make any false or forged prescription or written order for a controlled substance,
            
903

    
or to utter the same, or to alter any prescription or written order issued or written under the
            
904

    
terms of this chapter; or
            
905

    
    (iv)  to make, distribute, or possess any punch, die, plate, stone, or other thing designed
            
906

    
to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or
            
907

    
device of another or any likeness of any of the foregoing upon any drug or container or labeling
            
908

    
so as to render any drug a counterfeit controlled substance.
            
909

    
    (b)  Any person convicted of violating Subsection (3)(a) is guilty of a third degree
            
910

    
felony.
            
911

    
    (4)  Prohibited acts D -- Penalties:
            
912

    
    (a)  Notwithstanding other provisions of this section, a person not authorized under this
            
913

    
chapter who commits any act declared to be unlawful under this section, Title 58, Chapter 37a,
            
914

    
Utah Drug Paraphernalia Act, or under Title 58, Chapter 37b, Imitation Controlled Substances
            
915

    
Act, is upon conviction subject to the penalties and classifications under this Subsection (4) if
            
916

    
the trier of fact finds the act is committed:
            
917

    
    (i)  in a public or private elementary or secondary school or on the grounds of any of
            
918

    
those schools;
            
919

    
    (ii)  in a public or private vocational school or postsecondary institution or on the
            
920

    
grounds of any of those schools or institutions;
            
921

    
    (iii)  in those portions of any building, park, stadium, or other structure or grounds
            
922

    
which are, at the time of the act, being used for an activity sponsored by or through a school or
            
923

    
institution under Subsections (4)(a)(i) and (ii);
            
924

    
    (iv)  in or on the grounds of a preschool or child-care facility;
            
925

    
    (v)  in a public park, amusement park, arcade, or recreation center;
            
926

    
    (vi)  in or on the grounds of a house of worship as defined in Section 

76-10-501

;

            
927


    
    (vii)  in a shopping mall, sports facility, stadium, arena, theater, movie house,
            
928

    
playhouse, or parking lot or structure adjacent thereto;
            
929

    
    (viii)  in a public parking lot or structure;
            
930

    
    (ix)  within 1,000 feet of any structure, facility, or grounds included in Subsections
            
931

    
(4)(a)(i) through (viii);
            
932

    
    (x)  in the immediate presence of a person younger than 18 years of age, regardless of
            
933

    
where the act occurs; or
            
934

    
    (xi)  for the purpose of facilitating, arranging, or causing the transport, delivery, or
            
935

    
distribution of a substance in violation of this section to an inmate or on the grounds of any
            
936

    
correctional facility as defined in Section 

76-8-311.3

.
            
937

    
    (b)  A person convicted under this Subsection (4) is guilty of a first degree felony and
            
938

    
shall be imprisoned for a term of not less than five years if the penalty that would otherwise
            
939

    
have been established but for this subsection would have been a first degree felony.  Imposition
            
940

    
or execution of the sentence may not be suspended, and the person is not eligible for probation.
            
941

    
    (c)  If the classification that would otherwise have been established would have been
            
942

    
less than a first degree felony but for this Subsection (4), a person convicted under Subsection
            
943

    
(2)(g) or this Subsection (4) is guilty of one degree more than the maximum penalty prescribed
            
944

    
for that offense.
            
945

    
    (d) (i)  If the violation is of Subsection (4)(a)(xi):
            
946

    
    (A)  the person may be sentenced to imprisonment for an indeterminate term as
            
947

    
provided by law, and the court shall additionally sentence the person convicted for a term of
            
948

    
one year to run consecutively and not concurrently; and
            
949

    
    (B)  the court may additionally sentence the person convicted for an indeterminate term
            
950

    
not to exceed five years to run consecutively and not concurrently; and
            
951

    
    (ii)  the penalties under this Subsection (4)(d) apply also to any person who, acting with
            
952

    
the mental state required for the commission of an offense, directly or indirectly solicits,
            
953

    
requests, commands, coerces, encourages, or intentionally aids another person to commit a
            
954

    
violation of Subsection (4)(a)(xi).
            
955

    
    (e)  It is not a defense to a prosecution under this Subsection (4) that the actor
            
956

    
mistakenly believed the individual to be 18 years of age or older at the time of the offense or
            
957

    
was unaware of the individual's true age; nor that the actor mistakenly believed that the

            
958


    
location where the act occurred was not as described in Subsection (4)(a) or was unaware that
            
959

    
the location where the act occurred was as described in Subsection (4)(a).
            
960

    
    (5)  Any violation of this chapter for which no penalty is specified is a class B
            
961

    
misdemeanor.
            
962

    
    (6) (a)  Any penalty imposed for violation of this section is in addition to, and not in
            
963

    
lieu of, any civil or administrative penalty or sanction authorized by law.
            
964

    
    (b)  Where violation of this chapter violates a federal law or the law of another state,
            
965

    
conviction or acquittal under federal law or the law of another state for the same act is a bar to
            
966

    
prosecution in this state.
            
967

    
    (7)  In any prosecution for a violation of this chapter, evidence or proof which shows a
            
968

    
person or persons produced, manufactured, possessed, distributed, or dispensed a controlled
            
969

    
substance or substances, is prima facie evidence that the person or persons did so with
            
970

    
knowledge of the character of the substance or substances.
            
971

    
    (8)  This section does not prohibit a veterinarian, in good faith and in the course of his
            
972

    
professional practice only and not for humans, from prescribing, dispensing, or administering
            
973

    
controlled substances or from causing the substances to be administered by an assistant or
            
974

    
orderly under his direction and supervision.
            
975

    
    (9)  Civil or criminal liability may not be imposed under this section on:
            
976

    
    (a)  any person registered under [the Controlled Substances Act] this chapter who
            
977

    
manufactures, distributes, or possesses an imitation controlled substance for use as a placebo or
            
978

    
investigational new drug by a registered practitioner in the ordinary course of professional
            
979

    
practice or research; or
            
980

    
    (b)  any law enforcement officer acting in the course and legitimate scope of his
            
981

    
employment.
            
982

    
    (10) (a)  Civil or criminal liability may not be imposed under this section on any Indian,
            
983

    
as defined in Subsection 

58-37-2

(1)(v), who uses, possesses, or transports peyote for bona fide
            
984

    
traditional ceremonial purposes in connection with the practice of a traditional Indian religion
            
985

    
as defined in Subsection 

58-37-2

(1)(w).
            
986

    
    (b)  In a prosecution alleging violation of this section regarding peyote as defined in
            
987

    
Subsection 

58-37-4

(2)(a)(iii)(V), it is an affirmative defense that the peyote was used,
            
988

    
possessed, or transported by an Indian for bona fide traditional ceremonial purposes in

            
989


    
connection with the practice of a traditional Indian religion.
            
990

    
    (c) (i)  The defendant shall provide written notice of intent to claim an affirmative
            
991

    
defense under this Subsection (10) as soon as practicable, but not later than ten days prior to
            
992

    
trial.
            
993

    
    (ii)  The notice shall include the specific claims of the affirmative defense.
            
994

    
    (iii)  The court may waive the notice requirement in the interest of justice for good
            
995

    
cause shown, if the prosecutor is not unfairly prejudiced by the lack of timely notice.
            
996

    
    (d)  The defendant shall establish the affirmative defense under this Subsection (10) by
            
997

    
a preponderance of the evidence.  If the defense is established, it is a complete defense to the
            
998

    
charges.
            
999

    
    [(10)] (11)  If any provision of this chapter, or the application of any provision to any
            
1000

    
person or circumstances, is held invalid, the remainder of this chapter shall be given effect
            
1001

    
without the invalid provision or application.




 Legislative Review Note
    as of   5-18-05  1:30 PM

Based on a limited legal review, this legislation has not been determined to have a high
probability of being held unconstitutional.

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







